Barbieri JS - Search Results

1

Identifying Core Outcome Domains in Chronic Skin Disease Using the Best-Worst Scaling Method.

Shields A, Barg FK, Begolka WS, Sage K, Druby K, Gondo GC, Margolis DJ, Pusic AL, Barbieri JS. Shields A, et al. Among authors: barbieri js. JAMA Dermatol. 2024 Apr 1;160(4):441-446. doi: 10.1001/jamadermatol.2023.6245. JAMA Dermatol. 2024. PMID: 38381409

2

The reliability of teledermatology to triage inpatient dermatology consultations.

Barbieri JS, Nelson CA, James WD, Margolis DJ, Littman-Quinn R, Kovarik CL, Rosenbach M. Barbieri JS, et al. JAMA Dermatol. 2014 Apr;150(4):419-24. doi: 10.1001/jamadermatol.2013.9517. JAMA Dermatol. 2014. PMID: 24522374 Clinical Trial.

3

Duration of oral tetracycline-class antibiotic therapy and use of topical retinoids for the treatment of acne among general practitioners (GP): A retrospective cohort study.

Barbieri JS, Hoffstad O, Margolis DJ. Barbieri JS, et al. J Am Acad Dermatol. 2016 Dec;75(6):1142-1150.e1. doi: 10.1016/j.jaad.2016.06.057. Epub 2016 Aug 5. J Am Acad Dermatol. 2016. PMID: 27502311

4

Trends in prescribing behavior of systemic agents used in the treatment of acne among dermatologists and nondermatologists: A retrospective analysis, 2004-2013.

Barbieri JS, James WD, Margolis DJ. Barbieri JS, et al. J Am Acad Dermatol. 2017 Sep;77(3):456-463.e4. doi: 10.1016/j.jaad.2017.04.016. Epub 2017 Jul 1. J Am Acad Dermatol. 2017. PMID: 28676330

5

Influence of Market Competition on Tetracycline Pricing and Impact of Price Increases on Clinician Prescribing Behavior.

Barbieri JS, Margolis DJ, Brod BA. Barbieri JS, et al. J Invest Dermatol. 2017 Dec;137(12):2491-2496. doi: 10.1016/j.jid.2017.07.835. Epub 2017 Aug 24. J Invest Dermatol. 2017. PMID: 28842326 Free article.

6

The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications.

Ryskina KL, Goldberg E, Lott B, Hermann D, Barbieri JS, Lipoff JB. Ryskina KL, et al. Among authors: barbieri js. JAMA Dermatol. 2018 Apr 1;154(4):456-459. doi: 10.1001/jamadermatol.2017.6144. JAMA Dermatol. 2018. PMID: 29490358 Free PMC article.

7

Frequency of Treatment Switching for Spironolactone Compared to Oral Tetracycline-Class Antibiotics for Women With Acne: A Retrospective Cohort Study 2010-2016.

Barbieri JS, Choi JK, Mitra N, Margolis DJ. Barbieri JS, et al. J Drugs Dermatol. 2018 Jun 1;17(6):632-638. J Drugs Dermatol. 2018. PMID: 29879250

8

Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments.

Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Barbieri JS, et al. J Am Acad Dermatol. 2019 Feb;80(2):538-549. doi: 10.1016/j.jaad.2018.09.055. Epub 2018 Oct 5. J Am Acad Dermatol. 2019. PMID: 30296534 Free PMC article. Review.

9

Trends in Oral Antibiotic Prescription in Dermatology, 2008 to 2016.

Barbieri JS, Bhate K, Hartnett KP, Fleming-Dutra KE, Margolis DJ. Barbieri JS, et al. JAMA Dermatol. 2019 Mar 1;155(3):290-297. doi: 10.1001/jamadermatol.2018.4944. JAMA Dermatol. 2019. PMID: 30649187 Free PMC article.

10

Evaluation of Clinical Compendia Used for Medicare Part D Coverage Determinations for Off-label Prescribing in Dermatology.

Barbieri JS, St Claire K, Mostaghimi A, Albrecht J. Barbieri JS, et al. JAMA Dermatol. 2019 Mar 1;155(3):315-320. doi: 10.1001/jamadermatol.2018.5052. JAMA Dermatol. 2019. PMID: 30673082 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters